PEB:ASX
Pacific Edge Ltd
A$ ०.२२
०.००%
(०.००) 1D
नोभेम्बर ११, १५:४४:१६ GMT+११ · AUD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for PEB...
Mkt. cap
३४.२५ करोड
Avg. vol.
५७.९९ हजार
Volume
०.००
52-wk high
A$ ०.२६
52-wk low
A$ ०.१२
No. of employees
११४
Mkt. cap
३४.२५ करोड
Avg. vol.
५७.९९ हजार
Volume
०.००
52-wk high
A$ ०.२६
52-wk low
A$ ०.१२
No. of employees
११४
News stories
From web sources and news partners
Eurasia Business News
·
७ घण्टा पहिले
Stock Market Today: Dow Jones, Nasdaq, S&P 500 Rally on November 11, 2026; Oil Rises, Gold Slips
ChartMill
·
५ घण्टा पहिले
S&P 500 After-Hours Movers: MNST, RDDT Among Gainers; VEEV, LLY Among Losers in Latest Session
marketscreener.com
·
७ घण्टा पहिले
S&P 500's Earnings Growth to Slow in 2027, 2028, UBS Says
Traders Union
·
४ घण्टा पहिले
Peter Tuchman: S&P 500 gains over $900 billion in market cap, closing up 1.3 percent
Profile
Pacific Edge Limited, based in New Zealand, focuses on cancer diagnostics with a suite of bladder cancer diagnostic tools using genetic biomarkers. The company operates with a head office in Dunedin, New Zealand, and also has an office in Hershey, USA. It is listed on the Australian ASX and the New Zealand NZX main board stock exchange. Wikipedia
About Pacific Edge Ltd